Induction of peroxisomal enzyme activities by di-(2-ethylhexyl) phthalate in thyroidectomized rats with parathyroid replants
- PMID: 1469623
Induction of peroxisomal enzyme activities by di-(2-ethylhexyl) phthalate in thyroidectomized rats with parathyroid replants
Abstract
Previous studies suggest that thyroid hormones are involved in the mechanism of peroxisome proliferation. However, those studies utilized either surgically thyroidectomized animals, which are also parathyroidectomized, without calcium supplementation, or animals pretreated with antithyroid drugs, which are known to produce metabolic as well as morphometric changes in the liver. Therefore, these animal models confound conclusions drawn in previous studies. The purpose of the present study was to investigate the role of thyroid hormones in peroxisomal proliferation by the phthalate ester plasticizer, di-(2-ethylhexyl)phthalate (DEHP) in thyroidectomized rats with parathyroid replants. Using this model, it was found that DEHP-induced hepatomegaly was partially dependent on thyroid hormones. DEHP produced a thyromimetic effect, inducing the activity of malic enzyme and carnitine acetyltransferase in the absence of thyroid hormones. Additionally, DEHP-induced activities of catalase were shown to be dependent on thyroid hormones, whereas the thyroid status of the animal had no effect on DEHP-induced activities of the peroxisomal beta-oxidizing enzymes. These data further confirm that endocrine factors play variable roles in the process of induction of various peroxisomal enzymes caused by peroxisome proliferators.
Similar articles
-
Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.Cancer Res. 1988 Dec 1;48(23):6739-44. Cancer Res. 1988. PMID: 3180084
-
Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets.Arch Toxicol. 2007 Mar;81(3):219-26. doi: 10.1007/s00204-006-0141-x. Epub 2006 Aug 26. Arch Toxicol. 2007. PMID: 16937134
-
Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk.Crit Rev Toxicol. 1996 Jun;26(4):365-481. doi: 10.3109/10408449609048302. Crit Rev Toxicol. 1996. PMID: 8817083 Review.
-
Turnover of enzymes of peroxisomal beta-oxidation in rat liver.Biochim Biophys Acta. 1980 Jul 3;630(3):367-74. doi: 10.1016/0304-4165(80)90285-8. Biochim Biophys Acta. 1980. PMID: 7397231
-
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57. doi: 10.1006/rtph.1999.1296. Regul Toxicol Pharmacol. 1999. PMID: 10388618 Review.
Cited by
-
Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.PPAR Res. 2010;2010:681963. doi: 10.1155/2010/681963. Epub 2010 Oct 4. PPAR Res. 2010. PMID: 20953357 Free PMC article.
-
Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for Kupffer cells?J Carcinog. 2006 Nov 27;5:26. doi: 10.1186/1477-3163-5-26. J Carcinog. 2006. PMID: 17129391 Free PMC article.
-
Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643.J Carcinog. 2004 May 24;3(1):9. doi: 10.1186/1477-3163-3-9. J Carcinog. 2004. PMID: 15157275 Free PMC article.